Area of research
Immunology · Infectious Diseases
Research interest
Research focused on Peptide and Cancer immunotherapy, with related work in Immunotherapy, Pharmacology, Bioavailability. Notable publications include 'An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy', 'Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy', and 'Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4'.